The Journal of Pathology · 2008 · 31 citations · 13 references
MedicineMolecular BiologyOncologyChemotherapyMolecular OncologySignal TransductionCancer Cell SignalingChemotherapy ResistanceSignal Transduction In CancerTherapeutic ResistanceAnticancer Drug ResistanceC-jun N-terminal Kinase SignalingJnk Pathway ActivationJnk Signaling PathwayMultidrug Resistance ModulationProteasome-mediated DegradationRegulation By E3 Ubiquitin LigasesTherapeutic Resistance Mechanisms
Seven-in-absentia homologue 1 (Siah1) is an E3 ubiquitin ligase that regulates the ubiquitination and proteasome-dependent degradation of a number of proteins. Here we report that Siah1 modulates multidrug resistance 1 (MDR1)/P-glycoprotein-mediated drug resistance in the cancer cell lines examined. Siah1, but not its ligase-dead mutant, down-regulates MDR1/P-glycoprotein and sensitizes the multidrug-resistant cells to chemotherapeutic agents. Mechanistically, Siah1 does not promote P-glycoprotein degradation but decreases its expression transcriptionally by promoting c-Jun transcription factor binding to the activator protein 1 (AP1) site in the MDR1 promoter. Moreover, Siah1 triggers c-Jun NH2-terminal kinase (JNK) activation, leading to enhanced phosphorylation of c-Jun, and the JNK/c-Jun signalling axis is critical for Siah1 to down-regulate MDR1/P-glycoprotein expression. These findings demonstrate a previously unidentified role for Siah1 in regulating MDR1/P-glycoprotein expression through the JNK/c-Jun pathway.
13
Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs
Emma K. Baker, Ricky W. Johnstone, John Zalcberg et al. · Oncogene · 2005 · 193 citations
Jun Zhou, Min Liu, Ritu Aneja et al. · Cancer Research · 2006 · 111 citations
Medicine, Oncology, Pharmacology +15
Characterization of Gene Rearrangements Leading to Activation of MDR-1
Lyn M. Huff, Jongseok Lee, Robert W. Robey et al. · Journal of Biological Chemistry · 2006 · 57 citations · Full text